Integrin control of the transforming growth factor-β pathway in glioblastomaROTH, Patrick; SILGINER, Manuela; WELLER, Michael et al.Brain. 2013, Vol 136, pp 564-576, issn 0006-8950, 13 p., 2Article

Cilengitide (EMD 121974) arrests the growth of a heavily pretreated highly vascularised head and neck tumourRAGUSE, Jan-Dirk; GATH, Hans Joachim; BIER, Jürgen et al.Oral oncology (1997). 2004, Vol 40, Num 2, pp 228-230, issn 1368-8375, 3 p.Article

αv-Integrin isoform expression in primary human tumors and brain metastasesVOGETSEDER, Alexander; THIES, Svenja; INGOLD, Barbara et al.International journal of cancer (Print). 2013, Vol 133, Num 10, pp 2362-2371, issn 0020-7136, 10 p.Article

Cilengitide affects tumor compartment, vascularization and microenvironment in experimental bone metastases as shown by longitudinal ¹⁸F-FDG PET and gene expression analysisBRETSCHI, Maren; CAIXIA CHENG; WITT, Hendrik et al.Journal of cancer research and clinical oncology. 2013, Vol 139, Num 4, pp 573-583, issn 0171-5216, 11 p.Article

Phase I and correlative biology study of cilengitide in patients with recurrent malignant gliomaBURT NABORS, L; MIKKELSEN, Tom; DIMITRIOS COLEVAS, A et al.Journal of clinical oncology. 2007, Vol 25, Num 13, pp 1651-1657, issn 0732-183X, 7 p.Article

Phase I Clinical Trial of Cilengitide in Children With Refractory Brain Tumors : Pediatric Brain Tumor Consortium Study PBTC-012MACDONALD, Tobey J; STEWART, Clinton F; KUN, Larry E et al.Journal of clinical oncology. 2008, Vol 26, Num 6, pp 919-924, issn 0732-183X, 6 p.Article

Randomized phase II study of three doses of the integrin inhibitor cilengitide versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancerMANEGOLD, Christian; VANSTEENKISTE, Johan; CARDENAL, Felipe et al.Investigational new drugs. 2013, Vol 31, Num 1, pp 175-182, issn 0167-6997, 8 p.Article

Phase I/II trial of cilengitide with cetuximab, cisplatin and 5-fluorouracil in recurrent and/or metastatic squamous cell cancer of the head and neck: findings of the phase I partVERMORKEN, J. B; GUIGAY, J; MESIA, R et al.British journal of cancer. 2011, Vol 104, Num 11, pp 1691-1696, issn 0007-0920, 6 p.Article

Radiation sensitization of glioblastoma by cilengitide has unanticipated schedule-dependencyMIKKELSEN, Tom; BRODIE, Chaya; GOODMAN, Simon L et al.International journal of cancer (Print). 2009, Vol 124, Num 11, pp 2719-2727, issn 0020-7136, 9 p.Article

A Safety Run-In and Randomized Phase 2 Study of Cilengitide Combined With Chemoradiation for Newly Diagnosed Glioblastoma (NABTT 0306)NABORS, L. Burt; MIKKELSEN, Thomas; FISHER, Joy D et al.Cancer. 2012, Vol 118, Num 22, pp 5601-5607, issn 0008-543X, 7 p.Article

Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase 1/11 ADVANTAGE trial (phase II part)VERMORKEN, J. B; PEYRADE, F; BRÜMMENDORF, T. H et al.Annals of oncology. 2014, Vol 25, Num 3, pp 682-688, issn 0923-7534, 7 p.Article

Cilengitide inhibits metastatic bone colonization in a nude rat modelBRETSCHI, Maren; MERZ, Maximilian; KOMLJENOVIC, Dorde et al.Oncology reports. 2011, Vol 26, Num 4, pp 843-851, issn 1021-335X, 9 p.Article

Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma MultiformeREARDON, David A; FINK, Karen L; SCHIFF, David et al.Journal of clinical oncology. 2008, Vol 26, Num 34, pp 5610-5617, issn 0732-183X, 8 p.Article

Cilengitide targeting of α_vβ₃ integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenograftsBURKE, Patricia A; DENARDO, Sally J; MIERS, Laird A et al.Cancer research (Baltimore). 2002, Vol 62, Num 15, pp 4263-4272, issn 0008-5472Article

Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE-MRI in a longitudinal in vivo studyBAUERLE, Tobias; KOMLJENOVIC, Dorde; MERZ, Maximilian et al.International journal of cancer (Print). 2011, Vol 128, Num 10, pp 2453-2462, issn 0020-7136, 10 p.Article

Perspectives dans le traitement des Tumeurs CérébralesDHERMAIN, Frédéric; SANSON, Marc.Oncologie (Paris). 2008, Vol 10, issn 1292-3818, 7 p., SUP5Serial Issue